Percutaneous Liver Biopsy 

  • Author: Gaurav Arora, MS, MBBS; Chief Editor: Kurt E Roberts, MD   more...
 
Updated: Sep 13, 2011
 

Overview

Percutaneous liver biopsy is a procedure in which a long needle is introduced through the skin, subcutaneous tissues, intercostal muscles, and peritoneum into the liver to obtain a specimen of liver tissue.[1, 2] This procedure is usually performed on an outpatient basis. The patient is then observed for a few hours in the hospital or the ambulatory unit.

The liver biopsy needle used can be one of the following 3 types:

  • Cutting needle
  • Suction needle (discussed in this article)
  • Spring-loaded needle

This topic focuses on the technical aspects of performing a percutaneous liver biopsy. For a more detailed discussion of the theoretical aspects, please see Diagnostic Liver Biopsy.

Next

Indications

Initial diagnosis

  • Evaluation of abnormal liver test results, if all other workup is unrevealing[3]
  • Determination of stage of fibrosis and grade of inflammation for chronic hepatitis B and hepatitis C[4]
  • Evaluation of autoimmune hepatitis
  • Evaluation of a liver mass that does not exhibit typical imaging features of hepatocellular carcinoma (HCC)
  • Quantitative estimation of iron in hemochromatosis
  • Quantitative estimation of copper in Wilson disease
  • Estimation of the severity of alcoholic liver disease
  • Evaluation of drug toxicity
  • Evaluation of the suitability of a donor liver for transplantation
  • Diagnosis and staging of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
  • Evaluation of unexplained jaundice
  • Diagnosis of cholestatic liver disease
  • Evaluation of infiltrative or granulomatous disorders
  • Evaluation of liver injury from immunosuppressive agents (methotrexate)

Surveillance during treatment

  • Follow-up evaluation while on antiviral treatment for chronic hepatitis C (rare)
  • Monitoring of disease activity of autoimmune hepatitis during treatment (may assist in determining if therapy can be discontinued)

Posttransplant (liver)

  • Diagnosis of acute cellular rejection
  • Diagnosis of chronic rejection
  • Diagnosis of recurrent hepatitis C
  • Diagnosis of cytomegalovirus (CMV) hepatitis
  • Protocol biopsies to monitor for fibrosis or inflammation (particularly in patients who received liver transplants to treat liver failure in chronic hepatitis C)
Previous
Next

Contraindications

  • Uncooperative patient[5]
  • Inability to identify a suitable biopsy site by either percussion or ultrasonographic guidance
  • Prolonged (>1.5) international normalized ratio (INR)[6]
  • Decreased platelet count (< 60,000/mm3)
  • Bleeding diathesis (eg, hemophilia)
  • Recent use (within the last 7 days) of aspirin or nonsteroidal anti-inflammatory drugs (NSAID) or antiplatelet class of medications
  • Unavailability of blood products for transfusion
  • Morbid obesity of patient
  • Ascites
  • No backup support available from surgery or interventional radiology in case of a complication
  • Suspected hemangioma or hepatic echinococcal cysts
  • Abdominal wall infection over the identified biopsy site
  • Infection in the right pleural cavity or below the right hemidiaphragm
  • Bowel overlying biopsy site (on ultrasound or other abdominal imaging)
Previous
Next

Anesthesia

  • Local anesthesia with 1% or 2% lidocaine is used.
  • Some anxious patients may require a small oral or intravenous dose of a benzodiazepine (eg, lorazepam).
  • In rare cases, consideration may be given for the use of procedural sedation (eg, midazolam and fentanyl).
  • Overnight fasting by the patient is usually required prior to the procedure.
Previous
Next

Equipment

  • Patient consent form
  • Sterile gloves
  • Liver biopsy tray that contains the following items:
    • Core biopsy needle, preferably 16 gauge (ga), 4.5 inches
    • Povidone-iodine (eg, Betadine) solution
    • Formalin bottle (specimen container)
    • Injection needle, 21 ga, 1.5 inches
    • Injection needle, 25 ga, 1 inch
    • Sterile drape(s)
    • Saline solution (0.9%), 10-mL ampule
    • Surgical scalpel blade
    • Gauze pads, 3 X 3 inches
  • Appropriate vials for cultures and special stains, if indicated
Previous
Next

Positioning

  • The patient should be supine, with his or her right side near the edge of the bed.
  • The patient’s right arm should be above his or her head. Feet should be angled across the bed to expand the intercostal space as much as possible.
  • Adjust the height of the bed for comfort, usually at or slightly below the level of the elbows of the operator.
Previous
Next

Technique

  • Obtain written consent. Explain the benefits and risks of the procedure to the patient and make sure that he or she understands them well.
  • Percuss over the right upper quadrant to choose the biopsy site. The biopsy site is usually located in the seventh or eighth intercostal space in the midaxillary line. The site can be further confirmed with either routine ultrasonography or a bedside portable ultrasound machine.[7] Be sure to ascertain the direction and a safe depth for the biopsy needle, as shown in the image below. Also, be sure to eliminate the possibility of bowel juxtaposition along the biopsy tract. The video below depicts ultrasound-assisted percutaneous liver biopsy being performed. Ultrasonography of the liver. Ultrasonography of the liver. Hepatic parenchyma and blood vessels as seen on ulHepatic parenchyma and blood vessels as seen on ultrasound.
    Ultrasound-assisted percutaneous liver biopsy. Video courtesy of George Y Wu, MD, PhD.
  • Careful percussion can also be used to identify the site. Percuss along the midaxillary line and identify the point of maximal dullness at the end of maximal expiration by the patient, as shown below. This is usually found in either the seventh or eight intercostal space (corresponds to the second or third space above the right costal margin). Percussion over the liver. Percussion over the liver.
  • As in the image below, mark the identified site with a surgical pen. Marking the biopsy site. Marking the biopsy site.
  • Use the swab sticks to prepare the field. For field preparation, the operator may wear nonsterile gloves. Apply the povidone-iodine solution in a centrifugal fashion, starting from the mark and moving out in concentric circles, as shown below. Use all 3 sticks sequentially. Preparing the field. Preparing the field.
  • Remove the cover of the biopsy tray to reveal its contents, as shown in the photograph below. Check to see that all the necessary items are available. Liver biopsy tray. Liver biopsy tray.
  • Put on a sterile gown, cap, facial mask, and sterile gloves. Place sterile drape (found in the biopsy tray) as shown. Sterile drape application. Sterile drape application.
  • Aspirate lidocaine (1% or 2%) in a syringe, as shown below. Aspirating lidocaine. Aspirating lidocaine.
  • Infiltrate the skin over the site using a 25-ga needle attached to the lidocaine-filled syringe, as depicted in the image below. Infiltrating the skin at the biopsy site. Infiltrating the skin at the biopsy site.
  • Identify the xiphoid process by palpating over the drape, and use some mark to easily refer to it later. In this photograph, a gauze piece is used as a marker (see left upper corner). Administer further local anesthesia using a 21-ga needle in both superficial and deeper planes, extending down to the capsule of the liver. The deeper injection should be done while the patient is holding his or her breath in maximal expiration. Deeper injection of local anesthetic. Deeper injection of local anesthetic.
  • Using the second syringe from the tray, shown below, aspirate a minimum of 7-8 mL of sterile saline. Aspirating saline. Aspirating saline.
  • Unscrew the needle on the second syringe and attach the liver biopsy needle to this syringe, as shown below. Switching to biopsy needle. Switching to biopsy needle.
  • Using the provided surgical blade, make a small nick at the site so the biopsy needle can pass more easily through the skin, as shown below. This nick should be made at the upper border of the lower rib in the intercostal space to avoid injuring the neurovascular bundle that courses close to the lower border of the ribs. Making a skin nick. Making a skin nick.
  • The guard on the liver biopsy needle may be set beforehand based on the estimated depth required and the safety margin, which is based on the ultrasonographic results. Direct the needle as dictated by the ultrasonographic findings. If the percussion technique alone was used, the needle should be directed toward the xiphoid process and parallel to the ground. To avoid injury, introduce the biopsy needle in a similar fashion to that described for the blade in the previous step.
  • After penetrating through the skin and superficial subcutaneous tissues, keep the plunger of the syringe retracted while the needle is advanced as shown below. A series of popping sensations may be felt as the needle passes through the various tissue planes. Flush small amounts of saline once the needle has crossed the tissue planes and is close to the liver capsule to get rid of any tissues that may be blocking the needle tip. Penetrating tissue planes. Penetrating tissue planes.
  • Reapply suction on the needle by pulling back on the syringe plunger, and instruct the patient to exhale completely and hold the breath in maximal exhalation. This expiration is requested to avoid injury to the lungs and the gall bladder as well as to bring the liver in close proximity to the thoracic wall.
  • At this time, maintain suction on the syringe while pushing the needle into the liver to the depth and direction estimated previously and quickly removing the needle as shown below. This whole movement should not take more than 1 second and should be smooth in and out. The liver biopsy sample is thus obtained within the saline-filled syringe. Biopsy needle inside the liver. Biopsy needle inside the liver.
  • Unscrew the needle from the syringe. Pull the plunger back and gently take it off the syringe, as depicted in the image below, rather than trying to push the specimen forward through the opening of the syringe, which damages the specimen. Taking the plunger out. Taking the plunger out.
  • Empty the contents of the syringe into the formalin-containing bottle. Notice the liver biopsy sample in the bottle (white arrow in the image below). Cap the bottle tightly and then look through the side of the bottle to ascertain the approximate size of the sample. A sample about 1.5 cm in length and 1-2 mm in width is generally considered adequate. Transferring liver biopsy specimen to the formalinTransferring liver biopsy specimen to the formalin bottle.
  • Label the bottle. A liver biopsy sample thus obtained should be hand-delivered to the pathology laboratory rather than sending through the pneumatic tube system to avoid the small chance of it getting lost.
  • Apply pressure to the biopsy site for a few minutes, and then apply an adhesive bandage at the site. Instruct the patient to lie on the right side (as shown) for at least 2 hours. Patient lying on right side. Patient lying on right side.
  • The postprocedure orders sheet should be filled out at this time. Vital signs (blood pressure, heart rate, and pain level) should be obtained every 15 minutes for the first hour, every 30 minutes for the next hour, and, subsequently, every hour until discharge. A postprocedure observation time of 2 hours is considered adequate if no complications arise.[8] The patient should be observed closely for any symptom or sign of a complication.[9]
Previous
Next

Pearls

  • Proper identification of the biopsy site is of paramount importance.
  • The intrahepatic phase of the needle should be 1 second or less.
  • Limit the needle passes through the liver to no more than 3; a higher number of passes has been associated with increased risk of bleeding.
Previous
Next

Complications

  • Pain at the biopsy site or in the right shoulder (referred pain)
    • Most common adverse effect
    • Occurs in 25% of patients
    • Should not require more than 1 dose of an analgesic
  • Hypotension
    • Commonly caused by vasovagal reaction
    • Common cause of hospitalization (together with pain)
    • May be a sign of hemorrhage
  • Hemorrhage[10, 11]
    • Manifests as hypotension, tachycardia, and abdominal pain, usually within 3-4 hours of biopsy
    • Presentations include the following:
      • Subcapsular hemorrhage (usually asymptomatic; may cause pain)
      • Intrahepatic hemorrhage (usually asymptomatic)
      • Intraperitoneal hemorrhage (most serious bleeding complication; rare)
      • Hemobilia (very rare; 4 cases in a series of more than 68,000 patients)
  • Unintentional biopsy of other organs, such as lung, kidney, or colon (rare)
  • Biliary peritonitis (rare)
  • Transient bacteremia (mostly inconsequential)
  • Death (death rate 1 in 10,000-12,000 patients)[13, 14]
Previous
Next

Suggested Guidelines for Outpatient Liver Biopsy

These guidelines are modified from the American Gastroenterological Association’s 1989 position statement.[15]

  1. The patient must be able to easily return to the hospital where the procedure was performed within 30 minutes of developing any adverse symptoms.
  2. A reliable individual must be available to stay with the patient during the first night after the liver biopsy and provide care and transportation to the hospital, if necessary.
  3. The patient should not have any preexisting serious medical problems that might increase the risk of complications from the biopsy. Such problems may include encephalopathy, ascites, liver failure with severe jaundice, significant extrahepatic obstruction, significant coagulopathies, or serious comorbidities such as severe congestive heart failure. Also, patients should not be very old, very young, or so anxious that they require sedation.
  4. The facility where the biopsy is to be performed should have an approved laboratory, blood banking unit, easy access to an inpatient bed, and personnel to monitor the patient for 6 hours after the biopsy.
  5. The patient should be hospitalized after biopsy if any evidence exists of bleeding, bile leak, pneumothorax, or other organ puncture. Hospitalization is suggested if the patient’s pain requires more than 1 dose of an analgesic in the first 4 hours after the biopsy.
Previous
 
Contributor Information and Disclosures
Author

Gaurav Arora, MS, MBBS  Fellow in Gastroenterology and Hepatology, MD Anderson Cancer Center, University of Texas Medical School at Houston; Former Advanced Hepatology Fellow, Division of Gastroenterology and Hepatology, Liver Transplant Program, Stanford University School of Medicine

Gaurav Arora, MS, MBBS is a member of the following medical societies: American Association of Physicians of Indian Origin, American College of Gastroenterology, American Gastroenterological Association, and American Society of Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Coauthor(s)

Walid S Ayoub, MD  Clinical Assistant Professor of Medicine, Division of Gastroenterology and Hepatology and Liver Transplant Program, Stanford University School of Medicine

Disclosure: Nothing to disclose.

Emmet B Keeffe, MD, MACP  Professor of Medicine Emeritus, Stanford University Medical Center

Emmet B Keeffe, MD, MACP is a member of the following medical societies: American Association for the Study of Liver Diseases, American Clinical and Climatological Association, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Hepato-Pancreato-Biliary Association, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Transplantation, and European Association for the Study of the Liver

Disclosure: Romark Laboratories Salary Employment

Specialty Editor Board

Joseph K Lim, MD  Associate Professor of Medicine, Director, Yale Viral Hepatitis Program, Section of Digestive Diseases, Yale University School of Medicine

Joseph K Lim, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Luis M Lovato, MD  Associate Clinical Professor, University of California, Los Angeles, David Geffen School of Medicine; Director of Critical Care, Department of Emergency Medicine, Olive View-UCLA Medical Center

Luis M Lovato, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Kurt E Roberts, MD  Assistant Professor, Section of Surgical Gastroenterology, Department of Surgery, Director, Surgical Endoscopy, Associate Director, Surgical Skills and Simulation Center and Surgical Clerkship, Yale University School of Medicine

Kurt E Roberts, MD is a member of the following medical societies: American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, and Society of Laparoendoscopic Surgeons

Disclosure: Covidien Consulting fee Consulting; NovaTract Ownership interest Co-founder

Acknowledgments

We gratefully acknowledge the unnamed patient who graciously agreed to be photographed during the procedure for this article.

The authors and editors of eMedicine gratefully acknowledge the assistance of Lars Grimm with the literature review and referencing for this article.

Medscape Reference also thanks George Y Wu, MD, PhD, Professor, Department of Medicine, Director, Hepatology Section, Herman Lopata Chair in Hepatitis Research, University of Connecticut School of Medicine, for assistance with the video contribution to this article.

References
  1. Karamshi M. Performing a percutaneous liver biopsy in parenchymal liver diseases. Br J Nurs. Jun 26-Jul 9 2008;17(12):746-52. [Medline].

  2. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. May 2008;28(5):705-12. [Medline].

  3. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. Mar 1995;36(3):437-41. [Medline].

  4. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol. Jun 7 2008;14(21):3396-402. [Medline].

  5. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. Feb 15 2001;344(7):495-500. [Medline].

  6. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut. Oct 1999;45 Suppl 4:IV1-IV11. [Medline].

  7. Caturelli E, Giacobbe A, Facciorusso D, Bisceglia M, Villani MR, Siena DA, et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol. Jul 1996;91(7):1318-21. [Medline].

  8. Howard R, Karageorge G, van Harselaar K, Bell M, Basford P, Schultz M, et al. Post-procedure surveillance in liver biopsy: how long is long enough?. N Z Med J. Aug 22 2008;121(1280):8-14. [Medline].

  9. Firpi RJ, Soldevila-Pico C, Abdelmalek MF, Morelli G, Judah J, Nelson DR. Short recovery time after percutaneous liver biopsy: should we change our current practices?. Clin Gastroenterol Hepatol. Sep 2005;3(9):926-9. [Medline].

  10. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. Nov 1990;99(5):1396-400. [Medline].

  11. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci. Aug 1993;38(8):1480-4. [Medline].

  12. Orlando G, Goffette P, Gravante G, Ciccarelli O, Lerut J. Successful treatment of haemothorax following percutaneous liver biopsy using interventional radiology: importance of arterial anatomical variations. Transpl Int. Jul 2008;21(7):708-10. [Medline].

  13. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2(2):165-73. [Medline].

  14. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it?. Ann Intern Med. Jan 15 1993;118(2):150-3. [Medline].

  15. Jacobs WH, Goldberg SB. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci. Mar 1989;34(3):322-3. [Medline].

  16. American College of Physicians. Clinical Competence in Percutaneous Liver Biopsy. In: American College of Physicians Guidelines.

  17. Reddy KR, Schiff ER. Complications of Liver Biopsy. In: Taylor MB. Gastrointestinal Emergencies. 2nd. Baltimore, MD: Williams & Wilkins; 1996.

Previous
Next
 
Deeper injection of local anesthetic.
Infiltrating the skin at the biopsy site.
Aspirating saline.
Switching to biopsy needle.
Making a skin nick.
Penetrating tissue planes.
Biopsy needle inside the liver.
Taking the plunger out.
Transferring liver biopsy specimen to the formalin bottle.
Aspirating lidocaine.
Patient lying on right side.
Ultrasonography of the liver.
Hepatic parenchyma and blood vessels as seen on ultrasound.
Marking the biopsy site.
Liver biopsy tray.
Sterile drape application.
Percussion over the liver.
Preparing the field.
Ultrasound-assisted percutaneous liver biopsy. Video courtesy of George Y Wu, MD, PhD.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.